MitchellJF. Pharmacist involvement as a member of a renal transplant team. Am J Hosp Pharm1976; 33:55–8.
2.
PtachcinskiRJ, VenkataramananR, BurckartGJ. Clinical pharmacokinetics of cyclosporin. Clin Pharmacokinet1986; 11:107–32.
3.
VenkataramananR, HabuckyK, BurckartGJ. Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet1989; 16:134–61.
4.
VenkataramananR, SwaminathanA, PrasadT. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet1995; 29:404–30.
5.
PtachcinskiRJ, VenkataramananR, BurckartGJ. Cyclosporine—high-dose steroid interaction in renal transplant recipients: assessment by HPLC. Transplant Proc1987; 19:1728–9.
6.
D'MelloA, VenkataramananR, SatakeM. Pharmacokinetics of the cyclosporine–ketoconazole interaction in dogs. Res Comm Chem Pathol Pharmacol1989; 64:441–54.
7.
SteevesM, AbdallahHY, VenkataramananR. In-vitro interaction of a novel immunosuppressant, FK 506, and antacids. J Pharm Pharmacol1991; 43:574–7.
8.
WangCP, BurckartGJ, PtachcinskiRJ. Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients. Transplant Proc1988; 20:591–6.
9.
BurckartGJ, StarzlTE, VenkataramananR. Excretion of cyclosporine and its metabolites in human bile. Transplant Proc1986; 18:46–9.
PtachcinskiRJ, BurckartGJ, VenkataramananR, PtachcinskiRJ. Cyclosporine concentration determinations for monitoring and pharmacokinetic studies. J Clin Pharmacol1986; 26:358–66.
12.
ChisholmMA, MulloyLL, DiPiroJT. Comparing renal transplant patients’ adherence to free cyclosporine and free tacrolimus immunosuppressant therapy. Clin Transplant2005; 19:77–82.
13.
ChisholmMA, MulloyLL, JagadeesanM. Impact of clinical pharmacy services on renal transplant patients’ compliance with immunosuppressive medications. Clin Transplant2001; 15:330–6.
14.
ChisholmMA, MulloyLL, JagadeesanM. Effect of clinical pharmacy services on the blood pressure of African-American renal transplant patients. Ethn Dis2002; 12:392–7.
15.
ChisholmMA, LanceCE, MulloyLL. Patient factors associated with adherence to immunosuppressant therapy in renal transplant recipients. Am J Health Syst Pharm2005; 62:1775–81.
16.
FramptonJE, FauldsD. Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation. Pharmacoeconomics1993; 4:366–95.
17.
GaultMH, LongerichLL, VeyEG. Pharmacoeconomic comparison of cyclosporine oral solution and capsules after kidney transplantation. Nephron1993; 65:583–6.
18.
PartoviN, ChanW, NimmoCR. Evaluation of a patient education program for solid organ transplant patients. Can J Hosp Pharm1995; 48:72–8.
19.
CiminelliAM, DupuisR, WilliamsD. Patient education role of a pharmacist on a transplant service. Am J Health Syst Pharm2000; 57:767–8.
20.
Poveda AndrésJL, Font NogueraI, Monte BoquetE. Pharmacist's contribution to transplant patient care. Farm Hosp2006; 30:269–71.
21.
MonnierG, CharpiatB, SerratriceF. Evaluation of drug therapy knowledge in liver transplant patients after pharmacy counseling. Therapie2003; 58:305–11.
